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We measure the cytotoxicity of three metal complexes containing the 2,2′-bypyridine ligand,
Cu(bpy)(NCS)2, 1, [Cu(bpy)2(H2O)](PF6)2, 2, and Zn(bpy)2(NCS)2, 3, toward neuroblastoma cells (SK-
N-SH) and ovarian cancer cells (OVCAR-3) using two different cell assays. The cells were exposed to
various concentrations of the compounds for 1 h and the percent inhibition of cell growth, I, measured
for various times after exposure, i.e., as a function of the recovery time t. After developing the theory
showing the relationship between I and t, the cytotoxicity data were analyzed to reveal that the two
copper complexes, 1 and 2, cause the cells to divide at a slower rate than the controls during the recovery
period, but the zinc complex, 3, had little or no effect on cell division during the recovery period. The
usual metric for reporting cytotoxicity is IC50, which is the concentration of agent required to inhibit cell
growth to 50% of the control population. However, since IC50 can depend on the recovery time, t, as is
the case for 1 and 2, reporting IC50 for a single recovery time can hide important information about the
long-time effects of a cytotoxic agent on the health of the cell population. Mechanistic studies with
the compounds revealed that the copper complexes, 1 and 2, cleave closed circular pBR322 DNA in the
presence of ascorbate, while the zinc complex, 3, does not facilitate DNA cleavage under the same
conditions. This difference in DNA cleavage activity may be related to the fact that Cu(II) is redox
active and can readily change its oxidation state, while Zn(II) is redox inert and cannot participate in a
redox cycle with ascorbate to break DNA.
Introduction
Copper in its ionic forms is an important component in many
metallo enzymes and proteins in the body (1). Since aquated
copper, e.g., [Cu(H2O)6]2+, is toxic to cells, nature has developed
a sophisticated mechanism for sequestering and transporting the
ion from the point of its ingestion in the food supply to its
ultimate incorporation in critical biological components in the
cell. Imbalances in the normal levels of copper in the body lead
to aberrant conditions, one of which is the neurodegenerative
genetic disorder called Menkes disease. This disease, which is
characterized by reduced absorption of copper, is a childhood
disorder that produces delayed development, mental retardation,
and early mortality (2, 3). In contrast, Wilson’s disease, which
is characterized by an excess of copper in the body, leads to
reduced hepatic function and/or neurological problems that can
be Parkinson-like in nature. Copper ions are also important for
blood vessel development in tumors, and the ion is believed to
contribute to the growth, invasion, and metastasis of cancer (4).
In 1965, Dwyer and co-workers reported that the Cu2+
complex of 3,4,7,8-tetramethyl-1,10-phenanthroline inhibits the
growth of the Land-schuetz ascites tumor (5), and since this
early report, the anticancer properties of many copper complexes
containing, 1,10 phenanthroline (o-phen) and related ligands
have been actively investigated (4, 6–9). While the mechanism
by which these complexes exert their anticancer activity is not
known, it is possible that the compounds bind directly to target
molecules in the cell, or since copper can readily change its
oxidation state, they participate in redox chemistry that produces
radicals that damage biomolecules in the cell. Recently, Dou,
Verani, and their co-workers synthesized a group of Cu2+
complexes containing asymmetric tridentate donor ligands that
induce apoptosis in C4-2B and PC-3 human prostate cancer cells
(4, 10). Mechanistic studies with the compounds suggest that
they inhibit the chymotrypsin-like activity of the 20S proteasome
making them similar to the anticancer drug bortezomib, which
is used for treating multiple myeloma. The Casiopeı´nas are a
group of Cu2+ mixed-ligand antineoplastic agents which contain
1,10-phenanthroline or 2,2′-bipyridine (bpy) and other bidentate
ligands (11–13). These compounds exhibit cytotoxicity, geno-
toxicity, and antitumor effects, but their mode of action is
presently unknown.
Earlier, Koiri et al., reported that the complexes, M(bpy)-
(Ac)2·H2O, where M ) Cu(II) and Zn(II), bpy ) 2,2′-bipyridine
and Ac ) CH3CO2-, bind to purified lactate dehydrogenase,
LDH, and, when solutions of the compounds are perfused into
mice, they are able to reduce the levels of LDH in tissues and
organs (14). Since the inhibition of LDH blocks the intercon-
version of NADH and NAD+, a reaction that is critical for cell
survival, inhibiting the enzyme with small molecules could be
a useful strategy for killing cancer cells in chemotherapy
(15, 16).
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In this article, we measured the toxicity of Cu(bpy)(NCS)2,
1, [Cu(bpy)2(H2O)](PF6)2, 2, and Zn(bpy)2(NCS)2, 3, toward
neuroblastoma (SK-N-SH) and ovarian cancer (OVCAR-3) cells.
These cell lines were chosen because both neuroblastoma and
ovarian cancer cells have been previously used in studies with
copper and zinc complexes that are cytotoxic as well as in
studies with chelators that are believed to react with cellular
copper and zinc to produce compounds that are cytotoxic
(17–20). By measuring the percent inhibition of cell growth, I,
as a function of time after the cells have been exposed to the
metal complex, i.e., as a function of the recovery time, t, it was
found that surviving cells exposed to the zinc complex divide
normally during the recovery period, while those cells previously
exposed to the copper complexes divide more slowly during
the recovery period. After deriving the relationship between I
and t, we show that the measured value of IC50 for the two
copper complexes strongly depends on t, while IC50 for the zinc
complex is relatively independent of t. In light of earlier reports
that copper-phenanthroline complexes can be activated to
cleave DNA (21), we also studied the ability of the complexes
to cut closed circular pBR322 DNA in the presence of the
biologically common reducing agent, ascorbic acid.
Materials and Methods
Chemicals, Reagents, and Biological Supplies. 2,2′-Bipyridine,
zinc(II) nitrate dihydrate, and copper(II) nitrate dihydrate were
purchased from Sigma Aldrich and were used as received without
further purification. All of the solvents were purchased from E.
Merk and were freshly distilled prior to use. The complexes
Cu(bpy)(NO3)2·H2O and Cu(bpy)(MeCO2)2·H2O were synthesized
using the reported procedure (22), whereas [Zn(bpy)2(H2O)2]-
(LH3)2·7H2O was reported by us recently (23). Elemental analysis
and mass spectral measurements were carried out on a Carbo-Erba
elemental analyzer 1108, and JEOL SX-102 mass spectrometer
respectively. IR spectra were recorded as KBr pellets on a Varian
3100 spectrophotometer. The UV-vis measurements were made
in the range 200-800 nm using a Shimadzu UV-1701 spectropho-
tometer. Human neuroblastoma (SK-N-SH) cells and human ovarian
carcinoma (OVCAR-3) cells were purchased from the American
Type Culture Collection (ATCC Number HTB-11 and HTB-161).
Minimum essential medium with Earle’s salts and L-glutamine
(EMEM)(10-010), RPMI 1640, fetal calf serum (FCS), cell-stripper,
and trypan blue stain were from Mediatech (Herndon, VA). The
cell counting kits, CCK-F and CCK-8, which determine the number
of live cells in a population, were obtained from Dojindo Molecular
Technologies, Inc. (Gaithersburg, MD). For the DNA cleavage
studies, HEPES, agarose, Trizma base, boric acid, EDTA, and
ascorbic acid were purchased from Sigma-Aldrich (St. Louis, MO),
and the plasmid DNA (pBR322), 25 µg/µL, was from Invitrogen
(Carlsbad, CA).
Synthesis of the Complexes. The complexes 1-3 were synthe-
sized (Scheme 1) and characterized by spectroscopic techniques
as well as their single crystal X-ray crystallographic studies. The
details of the X-ray studies and thermal ellipsoid diagram of
complexes are given in Supporting Information.
Synthesis of Cu(bpy)(NCS)2, 1. A methanolic solution
(10 mL) of ammonium thiocyanate (0.152 g, 2.0 mmol) was
added dropwise to a methanolic solution (10 mL) of
Cu(bpy)(NO3)2·H2O (0.361 g, 1.0 mmol). The mixture was stirred
at room temperature for 2 h. A green colored precipitate was
filtered out, washed with methanol, and dried in Vacuo. The
complex was crystallized in DMF and methanol. Yield: 75%.
mp >530 °C. Elemental analysis calcd (%) for C12H8N4S2Cu:
C, 42.85; H, 2.38; N, 16.66. Found: C, 42.98; H, 2.59; N, 16.25.
IR (KBr pellet, cm-1): 1604 (υbpy), 2081 (υNCS), 771(υbpy). FAB-
MS (m/z (%)): 336 [M]+. UV-vis (DMSO, 10-4 M):
λmax/(nm) (εmax × 104 M-1 cm-1) 375 (3.11), 680 (0.113).
Synthesis of [Cu(bpy)2(H2O)](PF6)2, 2. A solution of
Cu(bpy)(MeCO2)2·H2O (0.711 g, 2.0 mmol) in DMF (10 mL) was
refluxed for 5 h on a sand bath followed by the addition of excess
of sodium acetate while stirring. After 5 h, the solution was filtered,
and an aqueous solution of NH4PF6 was added to the filtrate. A
solid crystalline product (light blue) was obtained, and single
crystals suitable for X-ray diffraction study were picked up. Yield:
61%. mp >230 °C. Elemental analysis calcd (%) for C20H18-
CuF12N4OP2: C, 35.13; H, 2.65; N, 8.19. Found: C, 35.18; H, 2.64;
N, 8.12. IR (KBr pellet, cm-1): 1601 (υbpy), 846 (υPF6), 771(υbpy).
FAB-MS (m/z (%)): 682(48) [M]+. UV-vis (DMSO, 10-4 M):
λmax/(nm) (εmax × 104 M-1 cm-1) 311 (3.86), 349sh (0.48), 691
(0.213).
Synthesis of Zn(bpy)2(NCS)2, 3. A solution of supramolecular
complex [Zn(bpy)2(H2O)2](LH3)2·7H2O (1.208 g, 1.0 mmol) in
DMSO (10 mL) was mixed with a solution of ammonium
thiocyanate (0.152 g, 2.0 mmol) in methanol (10 mL), and the
reaction was carried out by stirring at room temperature for 2 h.
Scheme 1. Outline of the Synthesis of the Metal Complexes Used in This Study Where LH3- Is the Anion of a Barbiturate
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The reaction mixture was left for slow evaporation at room
temperature. Block shaped colorless crystals were obtained after a
week. Elemental analysis calcd (%) for C22H16N4S2Zn: C, 53.44;
H, 3.24; N, 11.33. Found: C, 53.88; H, 3.39; N, 11.23. IR (KBr
pellet, cm-1): 1595 (υbpy), 2070 (υNCS), 771(υbpy). FAB-MS (m/z
(%)): 495 [M]+. UV-vis (DMSO, 10-4 M): λmax/(nm) (εmax × 104
M-1 cm-1) 280 (3.37).
Cytotoxicity Studies. The studies involving human neuroblas-
toma (SK-N-SH) cells and human ovarian carcinoma (OVCAR-
3) cells were carried out under standard conditions in a
humidified, 37 °C, 5% CO2 atmosphere in an incubator. The
culture medium used for SK-N-SH cells was Eagle’s minimum
essential medium (EMEM) to which had been added 10% fetal
calf serum (FCS), 100 µg/mL streptomycin, 100 IU/mL penicil-
lin, and 2.0 mM L-glutamine. The culture medium used for
OVCAR-3 was RPMI 1640 (Roswell Park Memorial Institute)
to which had been added 20% fetal calf serum (FCS), 100 µg/
mL streptomycin, 100 IU/mL penicillin, 2.0 mM L-glutamine,
and 10 µg/mL insulin. Four solutions of the complex in the
medium having concentrations 250, 500, 1000, and 2000 µM
were prepared by dissolving a weighed amount of complex in
0.3 mL of DMSO followed by the addition 5.7 mL of culture
medium to give the indicated final compound and DMSO (5%)
concentrations. To each of the 60 wells, 6 groups of 10 wells
each, in the central portions of four 96-well microplates were
added, medium alone containing no cells, Group 1, and medium
containing 5 × 104 cells/mL, Groups 2-6. The cells were
allowed to grow for 24 h reaching ∼30% confluency after which
time the medium was removed and replaced with 100 µL of
fresh medium containing 5% DMSO, Group 2, or 100 µL of
medium containing compound having concentrations of 250, 500,
1000, and 2000 µM for Groups 3-6, respectively. After an
exposure time to the copper/zinc compound of 1 h, the medium
in the wells containing cells was removed and replaced with
fresh medium, and the cells were allowed to recover for 2, 26,
50, and 74 h at the end of which time the number of live cells
was determined using the CCK-F assay according to the specified
protocol. The CCK-F assay relies on esterases in live cells to
convert a precursor compound into a calcein dye, the amount
of which can be quantitated by fluorescence. The viability of
SK-N-SH cells was also determined using a second method, the
CCK-8 assay, following the same procedure. The CCK-8 assay
relies on dehydrogenases in live cells to convert a tetrazolium
salt into formazan dye, the amount of which can be quantitated
by absorption spectroscopy. The concentrations of the copper/
zinc complex used were 25 µM, 250 µM, and 2500 µM.
The percent inhibition of 1-3 was calculated using eq 1, where
I is the percent inhibition, AD is the absorbance or fluorescence of
wells containing cells + culture medium + 5% DMSO, AT is the
absorbance or fluorescence of wells with cells containing culture
medium + 5% DMSO + the copper/zinc complex, AC is the
absorbance or fluorescence of wells with cells and culture medium,
and AM is the absorbance or fluorescence of wells without cells
but with culture medium.
DNA Cleavage Studies by Agarose Gel Electrophoresis. Six
solutions, 20 µL each, in 10 mM HEPES buffer (pH 7.4), each
containing various final concentrations of 1 (1, 2, 4, 6, 8, and
10 µM), 2, (10, 20, 40, 60, 80, and 100 µM), and 3 (10, 20, 30,
40, 50, and 60 µM) and plasmid DNA (33.3 µM base bairs)
were prepared. Since stock solutions of the complex were
prepared in a manner analogous to those described for the cell
studies, the reaction solutions also contained 5% DMSO. The
reaction solutions, along with solutions containing DNA alone
in 10 mM HEPES buffer with and without 5% DMSO, were
incubated at 37 °C for 30 min. After this time, a stock solution
of ascorbic acid (final concentration, 1.0 mM) was added to the
complex containing the solutions, and the resulting mixtures were
incubated at 37 °C for an additional 30 min to produce DNA
strand cleavage. As a control, DNA in buffer and 5% DMSO
was incubated with complexes 1 (5 and 10 µM), 2, and 3 (50
and 100 µM) for 0.5 h in the absence of ascorbic acid. Following
incubation, the reaction mixtures were quenched by rapid cooling
using dry ice, and 2.5 µL of a loading buffer containing 50%
glycerol, 0.25% bromphenol blue, and 0.25% xylene cyanol was
added to each sample. An 8 µL volume of each solution was
loaded onto a 1% (w/v) agarose gel in 0.5× (0.045 M Tris-
borate and 0.001 M EDTA) TBE buffer (pH 8.0), and electro-
phoresis was carried out at 100 V for 4 h. The gel was exposed
to a 5 × 10-5 % solution of ethidium bromide for 30 min and
washed (destained) in distilled water for 15 min. An image of
the gel was captured using a Kodak Gel Logic 100 imaging
system.
Results
Figures 1 and 2 show the percent inhibition, I, of SK-N-SH
neuroblastoma cells (Figure 1) and OVCAR-3 ovarian cancer
cells (Figure 2) by Cu(bpy)(NCS)2, 1, [Cu(bpy)2(H2O)](PF6)2,
2, and Zn(bpy)2(NCS)2, 3, as functions of concentration for
various recovery times. The curves shown in Figures 1 and 2
are the best fits to the function
where I is the percent inhibition of cell growth, R is the molar
inhibition parameter, and c is the concentration of the metal
complex. The measured percent inhibition I is equal to
where Nt is the number of live cells in a well treated with metal
complex and Nu the number of live cells in a well not treated
with 1-3; Nt/Nu is obtained from the absorbance or fluorescence
according to eq 1.
We suppose that the cells reproduce with growth constant k;
therefore, if the number of live cells at time 0 is No, the number
of live cells at time t is Noekt. If the only effect of the metal
complex is to kill a fraction of the cells, f, without affecting
the health of the surviving cells, the number of live cells at
time 0 is (1 - f)No, and the number of live cells at time t is (1
- f)Noekt. It is easy to see from eq 3 that I will be independent
of the recovery time t and always equal to 100f.
It is expected that f depends on the concentration of drug
used, c, becoming zero for c ) 0 and approaching 1 for cf ∞.
A simple representation of this is: f ) 1 - exp(-Rc), as used
in eq 2. For small c, f is proportional to c; the initial slope of
a plot of I vs c is 100R. The IC50 is simply equal to ln(2)/R.
This gives a single number for IC50 only in the simplest case,
when I depends on c but not on recovery time t. It is clear from
the calculated IC50 values, given in Table 1, as well as from
the initial slopes in Figures 1 and 2, that this is not at all the
case for the copper complexes considered here.
The initial slopes of the plots almost always increase with
the recovery time. The reason is that the copper complexes,
in addition to killing a fraction f of the cells during the time
that the cells are exposed to the agent, have a long-lasting
effect on the health of the surviving cells. They continue to
hinder the division of the surviving cells after the agent is
removed, i.e., during the recovery period. Thus, simply
measuring the IC50 by measuring f at one recovery time may
hide important information about this additional effect.
If the effects of the drug are long-lasting, so that the surviving
cells are in less than perfect health, then they will have a
decreased growth rate k′ with k′ < k. Then, assuming a fraction
I ) 100 × [ AD - ATAC - AM] (1)
I ) 100(1 - e-Rc) (2)
I ) 100(1 - Nt/Nu) (3)
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f of the original cells were killed, the number of treated cells at
time t is
and the percent inhibition is
Since exp[(k′ - k)t] in the last member is less than one, the
percent inhibition, I, will increase with t. For a fixed value of
t, let us abbreviate e(k′-k)t by C(t). Then, inserting the concentra-
tion dependence of f, f ) 1 - exp(-Rc), we have
It may be expected that C(t) depends on concentration c as
well as on t. However, the small number of data points in
the case of the metal complexes in this article (3 to 5 in
each case) and the relatively large experimental errors do
Figure 1. Percent inhibition of cell growth vs compound concentration on SK-N-SH cells. The cells were exposed to a compound for 1 h and
incubated on separate plates for 2, 26, 50, and 74 h before measurement. Data collected from CCK-8 and CCK-F assays were represented by
squares and diamonds, respectively. The curves were the best fits of eq 1 to the data from CCK-F assays. The first four panels, results for
Cu(bpy)(NCS)2, 1; next four panels, results for [Cu(bpy)2(H2O)2](PF6)2, 2; last four panels, results for Zn(bpy)2(NCS)2, 3.
Nt(t) ) (1 - f )Noek′t
I ) 100
Noe
kt - (1 - f )Noek′t
Noe
kt ) 100[1 - (1 - f )e(k′-k)t]
(4)
I ) 100[1 - C(t)e-Rc] (5)
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not justify using a two-parameter function to fit the data.
Thus we have used eq 2 instead of eq 5 in Figures 1 and 2,
corresponding to C ) 1. If, however, C(t) really decreases
with t, the second term in eq 5 will be smaller for larger t
values, which will appear as an increase in the value of R
(molar inhibition parameter) with t.
It is apparent from the figures that the fits to eq 2 are good
overall. This is shown by the values of r2 (goodness of fit),
which are calculated according to
Here Ij is the measured inhibition for the jth complex concentra-
tion, Ij is the mean value of Ij, and Ijcal the corresponding
Figure 2. Percent inhibition of cell growth vs compound concentration on OVCAR-3 cells. The cells were exposed to a compound for 1 h and
incubated on separate plates for 2 h, 26 h, 50 h, and 74 h before measurement. Data collected from CCK-F assays was represented by diamonds.
The curves were the best fits of eq 1 to the data from CCK-F assays. The first four panels, results for Cu(bpy)(NCS)2, 1; next four panels, results
for [Cu(bpy)(H2O)2](PF6)2, 2; last four panels, results for Zn(bpy)2(NCS)2, 3.
r
2 ) 1 -
∑
j
(Ij - Ijcal)2
∑
k
(Ij - Ij)2
(6)
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inhibition calculated according to eq 2. Table 1 shows the r2
values for all 24 conditions employed in this study, as well as
the molar inhibition parameter R for each.
As shown above, one can determine whether there are long-
lasting, effects on the cells (in addition to the initial cell kill
produced by exposure to the agent) by considering how the
molar inhibition parameter R depends on recovery time t. If,
for example, the agent hinders cell division but the cells remain
competent to register as being alive with a standard cell assay,
R will increase with t. If there are no effects of the agent on
the cells after the initial kill, R will be constant or independent
of t during the recovery period.
In order to determine whether R depends on t, we have
performed linear fits on all six data sets given in Table 1 (of
course, it is not expected that R is a linear function of t; the
linear fits are simply to establish slopes). The following results
were obtained. For 1, the slope is (7.8 ( 3.1) × 10-6 µM-1 h-1
for SK-N-SH and (5.7 ( 2.0) × 10-5 µM-1 h-1for OVCAR-3,
i.e., the slope is definitely positive. This indicates that, in
addition to killing some cells during the 1 h exposure time,
compound 1 produces long-term effects, in that cells divide more
slowly during the recovery period. For 2, the slope is (1.6 (
0.4) × 10-6 µM-1 h-1 for SK-N-SH and (1.9 ( 1.4) × 10-5
µM-1 h-1 for OVCAR-3. Since these slopes are definitely
positive, 2 also slows cell division during the recovery period.
For 3, the slope is (3.8 ( 6.6) × 10-6 µM-1 h-1 for SK-N-SH
and (-1.7 ( 1.8) × 10-6 µM-1 h-1 for OVCAR-3, i.e., the
slopes are essentially zero in both cases. Thus, the zinc complex
differs from the copper complexes in that the latter complex
hinders cell division during recovery, but the zinc complex,
which, like the copper complexes, kills cells during the exposure
period, does not affect cell division during the recovery period.
It is implied that IC50 may depend on recovery time if the
agent being tested affects the division rate of cells after exposure
to the agent. In Figures 3 and 4 and Table 2, we consider how
the ratio of treated to nontreated cells, Nt/Nu, depends on t for
a fixed concentration of the complex. If there are no effects on
division, Nt/Nu will be independent of t, but if division is
hindered due to exposure to the agent, Nt/Nu will decrease with
t. It may also happen that Nt/Nu increases with t, which means
that the surviving cells divide more rapidly than the untreated
cells after exposure to the agent. Table 2 shows the results of
linear fits of Nt/Nu vs recovery time for a fixed concentration of
the metal complex. For the copper compounds, the slope is
definitely negative (magnitude of the slope greater than the
standard error) for both assays and both cell types except for
one case. For SK-N-SH cells with the CCK-8 assay and 25 µM
1, the slope is negative, but its magnitude is less than the
standard error, indicating that the slope is statistically zero. It
is clear that the two copper complexes diminish the reproductive
capacity of the cells which survive the initial exposure to the
complex.
For the zinc compound, 3, the situation is quite different in
that the slope is statistically zero in three cases, statistically
negative in only one case, and statistically positive in five cases.
This shows that the reproductive capacity of the surviving cells
which have been exposed to the zinc complex is certainly not
diminished; in fact, the metal complex may even enhance
division.
Finally, we compare the results of the two assays, CCK-8
and CCK-F, for neuroblastoma, SK-N-SH cells (Figure 1). In
the CCK-8 assay, a tetrazolinum salt is taken up by a live cell
and reduced by dehydrogenases to a formazan dye, the
concentration of which is measured by absorption spectroscopy.
In the CCK-F assay, a fluorescein precursor is taken up by a
live cell and hydrolyzed by esterases to a fluorescein dye, which
is detected by fluorescence. As is evident in Figure 1, in 32 out
of 36 points, the measured inhibition for the CCK-8 assay is
within one standard deviation of the curve obtained by fitting
the inhibitions measured using the CCK-F assay. The agreement
suggests that both assays are detecting the same number of live
cells.
Since copper-o-phenanthroline complexes are known to
cleave DNA in the presence of activating agents (21), the ability
of the 2,2′-bipyridine compounds 1-3 to cleave the closed
circular pBR322 DNA in the presence and absence of ascorbate
was also studied. As is evident from Figure 5, 1 and 2 can be
activated by ascorbate to cut closed circular DNA, eventually
reducing the plasmid to low molecular weight fragments, which
appear as an ethidium bromide-stained streak in the gel. This
behavior contrasts with that of Zn(bpy)2(NCS)2, 3, Figure 5c,
which produces no DNA cleavage in the presence of ascorbate.
In the absence of ascorbic acid, none of the complexes produced
DNA cleavage (Figure 5d).
Discussion
In this work, we report the synthesis, characterization, and
cytotoxic properties of Cu(bpy)(NCS)2, 1, [Cu(bpy)2(H2O)]-
(PF6)2, 2, and Zn(bpy)2(NCS)2, 3. Structurally, 1 is a 4-coor-
dinate approximately square planar Cu(II) complex with N-
bonded thiocyanate ligands, 2 is a 5-coordinate, trigonal
bipyramidal Cu(II) complex with a coordinated water molecule,
and 3 is a 6-coordinate approximately octahedral Zn(II)
compound with two N-bonded thiocyanate ligands (Scheme
1and Supporting Information). The cytotoxicities of the metal
Table 1. Molar Inhibition Parameter, r, r2 and IC50 Values for All Complexes and Recovery Times, Derived from the Results
Plotted in Figures 1 and 2a
SK-N-SH cells OVCAR-3 cells
complex, recovery time R (µM-1) r2 IC50(µM) complex, recovery time R (µM-1) r2 IC50(µM)
1, 2 h 0.000148 0.699 4683 1, 2 h 0.000120 0.628 5776
1, 26 h 0.000190 0.490 3648 1, 26 h 0.000914 0.857 758
1, 50 h 0.000266 0.895 2606 1, 50 h 0.001227 0.880 565
1, 74 h 0.000645 0.956 1075 1, 74 h 0.004606 0.712 150
2, 2 h 0.000700 0.594 990 2, 2 h 0.000117 0.265 5924
2, 26 h 0.001419 0.723 488 2, 26 h 0.000803 0.924 863
2, 50 h 0.001728 0.745 401 2, 50 h 0.002144 0.940 323
2, 74 h 0.001840 0.782 377 2, 74 h 0.001221 0.679 568
3, 2 h 0.000493 0.978 1406 3, 2 h 0.000534 0.936 1298
3, 26 h 0.001238 0.865 560 3, 26 h 0.000676 0.862 1025
3, 50 h 0.001010 0.822 686 3, 50 h 0.000490 0.830 1415
3, 74 h 0.000873 0.818 794 3, 74 h 0.000463 0.798 1497
a Cu(bpy)(NCS)2, 1, [Cu(bpy)2(H2O)](PF6)2, 2, and Zn(bpy)2(NCS)2, 3.
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complexes toward neuroblastoma, SK-N-SH, and ovarian
cancer, OVCAR-3, were measured using two standard assays
that detect the number of live cells in a population. Cells were
exposed to the compound for 1 h. In order to uncover long
lasting effects that the complexes may have on the cells after
exposure, the number of living cells was determined for different
recovery times. The results reveal that the copper complexes, 1
and 2, impair the ability of the cells to divide, whereas the zinc
complex, 3, has no, or possibly a weak stimulating, effect on
cell division during the recovery period (Figures 1 and 2 and
Table 1). We point out that, since IC50, the concentration of
agent required to inhibit cell growth to 50% of the control
population, is equal to ln(2)/R, and R, the molar inhibition
parameter, can depend on recovery time, reporting IC50 for a
single recovery time can hide important information concerning
the health of the population after exposure to the toxin.
In this case, the hidden information is that while the copper
complexes, 1 and 2, kill some of the SK-N-SH and OVCAR-3
cells during the 1 h exposure period, the compounds also have
a longer-lasting effect on the surviving cells, causing them to
Figure 3. Ratio Nt/Nu is plotted against recovery time t for a fixed concentration of agent, where Nt ) number of cells in treated population, and
Nu ) number of cells in untreated population. Nt and Nu were measured using the CCK-F assay. The first six plots are for compound 1, the next
six for compound 2, and the last six for compound 3. For the copper compounds 1 and 2, Nt/Nu decreases with t, but this is not the case for the zinc
compound 3.
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divide more slowly than cells of a control group. This is shown
in the slopes of plots of Nt/Nu vs recovery time t (Figures 3 and
4 and Table 2). The longer the value of t, the greater the apparent
inhibition (proportional to 1 - Nt/Nu) for a given concentration
of compound. This means longer t lowers the apparent value
of IC50, i.e., the compounds appear more cytotoxic for larger t.
As shown in Table 1, the IC50 of the two copper complexes 1
and 2 is diminished by more than an order of magnitude when
the recovery time is increased from 2 to 74 h for both cell lines
studied. Structurally, 1 contains one 2,2′-bipyridine ligand, and
the compound is uncharged, while 2 has two 2,2′-bypyridine
ligands, and the complex is a divalent cation (Scheme).
Interestingly, 2 is clearly more toxic than 1 toward neuroblas-
toma cells, but there is no apparent difference in the toxicity of
the compounds toward the ovarian cancer cell line (Table 1).
Determining if this difference in cytotoxicity toward the two
cell lines is related to the charge on the compounds and the
mechanism by which they are transported into the cell and/or
the number of attached 2,2′-bipyridine ligands attached to the
metal ion will require additional study.
As is evident from Table 1, the zinc complex 3 does not show
a decrease in IC50 with t, as do the copper complexes.
Correspondingly, the slopes in Table 2, representing the time
derivatives of Nt/Nu, are definitely negative for all concentrations
of both copper complexes but probably positive for most of
the zinc complex results. Thus, it may be that 3 enhances the
ability of cells that survive the initial attack to divide or that
the cells which survive the attack by 3 are also those which
inherently divide faster than the others in the population. This
would be an example of drug-induced resistance, since cells
which survive treatment are healthier than before. It is interesting
that the copper complexes do not have the same effect.
We are unaware of any published study which analyzes, as
described herein, the dependence of inhibition on recovery time,
Figure 4. Ratio Nt/Nu is plotted against recovery time t for a fixed concentration of agent, where Nt ) number of cells in treated population, and
Nu ) number of cells in untreated population. Nt and Nu were measured using the CCK-8 assay. The first three plots are for complex 1, the next
three for complex 2, and the last three for complex 3. For the copper compounds 1 and 2, Nt/Nu decreases with t, but this is not the case for the
zinc compound 3.
Table 2. Slopes with Errors of Plots of Nt/Nu vs Time for a
Fixed Concentration of Complexa
compound cells assay
concn
(µΜ)
slope
(h-1)
error
(h-1)
sign
of slope
1 SK-N-SH CCK-F 500 -0.00824 0.00292 -
1000 -0.00458 0.00199 -
2000 -0.00114 0.00020 -
CCK-8 25 -0.00217 0.00348 0
250 -0.00722 0.00366 -
2500 -0.00623 0.00203 -
OVCAR-3 CCK-F 500 -0.00884 0.00411 -
1000 -0.01336 0.00542 -
2000 -0.00535 0.00471 -
2 SK-N-SH CCK-F 500 -0.01281 0.00173 -
1000 -0.00676 0.00232 -
2000 -0.00460 0.00135 -
CCK-8 25 -0.00194 0.00019 -
250 -0.00401 0.00089 -
2500 -0.00717 0.00234 -
OVCAR-3 CCK-F 500 -0.01281 0.00173 -
1000 -0.01192 0.00135 -
2000 -0.00885 0.00453 -
3 SK-N-SH CCK-F 500 0.00091 0.00201 0
000 -0.00236 0.00318 0
2000 -0.00415 0.00315 -
CCK-8 25 0.00336 0.00023 +
250 0.00351 0.00073 +
2500 0.00375 0.00238 +
OVCAR-3 CCK-F 500 0.00119 0.00065 +
1000 0.00369 0.00088 +
2000 -0.00119 0.00192 0
a Cu(bpy)(NCS)2, 1, [Cu(bpy)2(H2O)](PF6)2, 2, and Zn(bpy)2(NCS)2, 3.
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in order to obtain information about long-time effects of a
cytotoxic agent on cells which survive treatment. However,
recovery time was noted to be important in Murine leukemia
L1210 cells treated with cisplatin, in that low concentrations
of the drug caused the cells to be transiently arrested in the G2
phase for about 3 days before this phase is bypassed, and growth
is resumed (24). In another study, cisplatin analogues containing
sulfur carrier ligands affected the growth of MCF7 human breast
cancer cells during the recovery period (25). Interestingly, in
this study both inhibitory and stimulatory effects on cell division
were observed, depending on the platinum complex being
investigated. This makes the reported value of IC50 strongly
dependent on the time (recovery period) at which inhibition is
measured.
Obviously, the amount of inhibition observed for a cell
population depends not only on the concentration of cytotoxic
agent but also on the length of time that the cells are in contact
with the agent, the exposure time. It is believed that the relevant
parameter is the AUC, the area under the curve, giving drug
concentration vs time (2). If this curve resembles a rectangle,
then AUC ) concentration × exposure time. In an earlier study
by us involving Jurkat cells and cisplatin (26), the percent
viability of the cell population measured 24 h after exposure to
the drug correlated inversely with AUC, where AUC was
calculated as the product of exposure time and drug concentra-
tion. If the amount of cell death in fact depends only on AUC,
one can obtain the same information about inhibition using any
convenient exposure time. We have used 1 h in the experiments
presented here. In a very crude way, this approximates a short
i.v. administration of cisplatin and its rapid clearance from blood,
t1/2 ∼0.5 h (2).
While this study provides no detailed mechanistic information
on how the 2,2′-bipyridine complexes are able to kill neuro-
blastoma and ovarian cancer cells, the fact that all of the
complexes have the bpy ligand and only the copper complexes
are cytotoxic suggests that the coordinated copper ion is
important in slowing the division of and killing cells. Since it
is known that Cu(II) in the biological system can facilitate the
production of the hydroxyl radical, hydrogen peroxide, and
superoxide, collectively referred to as ROS (2, 21, 27), it
possible that 1 and 2 induce ROS which damage biological
molecules in the cell. This mechanism, which may be operating
in observed radical damage to biological molecules in Alzhe-
imer’s disease, requires a reducing agent, molecular oxygen,
and a change in oxidation state of the copper ion (2). Since
DNA is an important target for anticancer agents, we investi-
gated the ability of 1-3 to cleave closed circular pBR322 DNA.
As is evident in Figure 5a and b, the two copper compounds, 1
and 2, facilitate breakage of closed circular pBR322 DNA in
the presence of an excess of the common biological reducing
agent ascorbic acid in a manner which is dependent on the
concentration of the complex present in the medium. Since
molecular oxygen was not excluded in the reaction, this
observation is consistent with copper mediated damage to DNA
through the production of ROS (2). Figure 5c also shows that
the zinc complex, 3, cannot break DNA under the same
activating conditions. Since Zn(II) cannot easily change its
oxidation state, this observation is also consistent with 1 and 2
damaging DNA via a ROS generating type mechanism. In the
absence of ascorbic acid, none of the complexes cut pBR322
DNA, Figure 5d, which shows the importance of the reducing
agent in the cleavage process.
Earlier, it was suggested that lactate dehydrogenase, LDH,
may be a biological target for M(bpy)(Ac)2·H2O, where M )
Cu(II) and Zn(II), bpy ) 2,2′-bipyridine, and Ac ) CH3CO2-,
compounds which are similar in structure to 1-3 (14). The
CCK-8 cell assay used in this investigation requires viable
cellular dehydrogenases for reducing a tetrazolium salt to a
formazan dye, while the CCK-F assay requires viable esterases
for producing a detectable fluorophore for quantitating the
number of live cells. In view of the fact that both assays, within
error, yield the same number of live cells, it would seem that
the killing mechanism used by these compounds does not
involve either esterases or dehydrogenases. Clearly, additional
work will be needed to uncover the molecular mechanism by
which these interesting compounds kill cancer cells.
Figure 5. Agarose gel electrophoresis images of 1 (a), 2 (b), and 3 (c) cleavage of pBR322 DNA in the presence of the activator, ascorbic acid (1
mM, 0.5 h), and a control group (d) showing the effects of the metal complexes alone on DNA in the absence of the activator. The studies were
done in 1 mM HEPES buffer with 5% (v/v) DMSO, pH 7.4, at 37 °C. In panels a-c, lane 1, DNA alone; lane 2, DNA plus 5% DMSO; lane 3,
DNA with ascorbic acid, no complex. (a) For lanes 4-6, which contained ascorbic acid, the lane numbers and [1]/[DNA-base pairs] are as follows:
4, 0.03; 5, 0.06; 6, 0.12; 7, 0.18; 8, 0.24; 9, 0.30. (b) For lanes 4-6, which contained ascorbic acid, the lane numbers and [2]/[DNA-base pairs] are
as follows: 4, 0.3; 5, 0.6; 6, 1.2; 7, 1.8; 8, 2.4; 9, 3.0. (c) For lanes 4-6, which contained ascorbic acid, the lane numbers and [3]/[DNA-base pairs]
are as follows: 4, 0.3; 5, 0.6; 6, 0.9; 7, 1.2; 8, 1.5; 9, 1.8. A control group without ascorbic acid is shown in panel d. Lane 1, DNA alone; lane 2,
DNA plus 5% DMSO. For lanes 3 and 4, [1]/[DNA-base pairs] are 0.15 and 0.30; for lanes 5 and 6, [2]/[DNA-base pairs] are 0.3 and 3.0; for lanes
7 and 8, [3]/[DNA-base pairs] are 0.3 and 3.0. After electrophoresis, the DNA was stained with ethidium bromide.
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Conclusions
The cytotoxicities of three compounds, Cu(bpy)(NCS)2, 1,
[Cu(bpy)2(H2O)](PF6)2, 2, and Zn(bpy)2(NCS)2, 3, toward
neuroblastoma, SK-N-SH, and ovarian cancer, OVCAR-3, cells
were measured. Cells were exposed to a metal complex for 1 h,
after which the agent was removed and the number of live cells
measured using two standard cell counting assays. For the two
copper complexes, the results depend strongly and interestingly
on the time allowed to elapse between the removal of the metal
complex and the measurement of the number of live cells in
the population, i.e., the recovery time t, showing that the
measured value of IC50 strongly depends on the recovery time.
We suggest that when measuring the cytotoxicity of an agent
in a cell study it is important to measure the percent inhibition
and IC50 at various recovery times, which will uncover the long-
term effects of the toxin on the health of the cell population. In
contrast to the copper complexes, the zinc complex, 3, was only
weakly cytotoxic and had little or no effect on cell division
during the recovery period.
This study also showed that in the presence of ascorbate,
Cu(bpy)(NCS)2, 1, and [Cu(bpy)2(H2O)](PF6)2, 2, cleave closed
circular pBR322 DNA, while Zn(bpy)2(NCS)2, 3, cannot induce
DNA strand scission, an observation which is consistent with
the redox inertness of the Zn(II) ion in 3. Additional work will
be needed to determine if DNA and/or proteins are targets for
these metal complexes in the cell.
Supporting Information Available: X-ray crystallographic
data [deposited in the Cambridge Crystallographic Data Centre
as CCDC 771189 (complex 1), 647959 (complex 2) and 647855
(complex 3)] collection details, figures showing thermal el-
lipsoids, and a table for crystallographic data. This material is
available free of charge via the Internet at http://pubs.acs.org.
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